Octreotide combined ligation of esophageal varices.doc

 PAGE \* MERGEFORMAT 8 Octreotide combined ligation of esophageal varices 【Abstract】 Objective endoscopic variceal ligation (endoscopic variceal ligation, EvL) Octreotide treatment of esophageal varices combined cure rate. Methods of December 2002 -2,008 12-month period, Jilin City Central Hospital, Gastroenterology 101 cases of liver cirrhosis or liver cancer in patients with esophageal varices after EVL to continue to use octreotide maintenance treatment information, analysis EVL combined administration of octreotide treatment in patients with The more the rate of early rebleeding features. The results of EVL octreotide treatment of acute esophageal variceal bleeding control rate of 101/99 (98.0%), early rebleeding rate of 101 / 6 (5.9%), the average bleeding time was 7.0 ± 3 (h). Blood transfusion during the treatment volume 500 ± 450 (ml), hospitalization days 16 ± 3 (d), complication rate was 101 / 8 (7.92%). Conclusion esophageal variceal bleeding application of endoscopic variceal ligation combined octreotide in the treatment results were satisfactory. Keywords: esophageal variceal ligation of esophageal varices combined Octreotide high cure rate Esophageal variceal bleeding is a serious complication of cirrhosis of the liver, oncoming force tumultuous, bleeding volume, a high fatality rate, is an emergency medical system, severe, there is no international uniform treatment, I am being taken to hospital and intravenous infusion of octreotide in Endoscopic esophageal variceal ligation therapy is the treatment of esophageal variceal bleeding is an important tool. This paper retrospectively observed the intravenous infusion of octreotide combined EVL treatment of esophageal variceal bleeding effects and complications, and to analyze whether the increase of octreotide combined EVL treatment of esophageal variceal bleeding effect, now in our hospital in December 2002 -- in December 2008 during the period 101 cases of liver cirrhosis esophageal